Volume 16, Number 2—February 2010
Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies1
|1||Minimum pharmaceutical intervention|
|2||Antiviral treatment of those clinically infected|
|3||Population prepandemic vaccination|
|4||Strategies 2 + 3|
*All strategies included an initial antiviral containment effort and distribution of a matched vaccine to the population 180 days after the first locally acquired case.
1This material was compiled before the declaration of pandemic (H1N1) 2009 and concerns stockpiling for a future influenza pandemic.